Evidence map›Paper›PMID 40143868›Full record

SynthesisFrontiers in microbiology2025

Effect of

Qiang Fu, Huidong Yu, Ming Liu, Liang Chen, Weiyang Chen, Ziyi Wang, Wenya Li

Abstract readSystematic Review
In one paragraph

Synthesis in Frontiers in microbiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Review
  2. Gastric intestinal metaplasia: Management and surveillance strategies.World journal of gastrointestinal pathophysiology · 2026
    Review
  3. Deciphering whipple's disease complexity.Clinical and experimental medicine · 2026
    Review
  4. Article
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Qiang Fu *Department of Thoracic Surgery, The First Hospital of China Medical University, Shenyang, China.
Huidong Yu *Department of Thoracic Surgery, The First Hospital of China Medical University, Shenyang, China.
Ming LiuDepartment of Thoracic Surgery, The First Hospital of China Medical University, Shenyang, China.
Liang ChenDepartment of Thoracic Surgery, The First Hospital of China Medical University, Shenyang, China.
Weiyang ChenDepartment of Thoracic Surgery, The First Hospital of China Medical University, Shenyang, China.
Ziyi WangState Key Laboratory of Molecular Oncology, National Cancer Center, National Clinical Research Center for Cancer, Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Wenya LiDepartment of Thoracic Surgery, The First Hospital of China Medical University, Shenyang, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Observational studies suggest that Methods: PubMed, Embase, Cochrane Library, Web of science and China National Knowledge Internet database were searched for RCTs published through May 2024 in adults with IM or dysplasia comparing the risk of gastric cancer following Results: Sixteen RCTs involving 15,027 patients with IM or dysplasia met the inclusion criteria. In a pooled analysis, Conclusion: Systematic review registration: INPLASY202530010, https://inplasy.com/.

Indexed as

cancer riskdysplasiagastric cancerHelicobacter pyloriintestinal metaplasiameta-analysisprecursor

Identifiers

PMID40143868
PMCPMC11938427

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.